NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia
β Scribed by J. Karle; H. Lublin; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Andersen; C. Fensbo; M. Sloth-Nielsen; B. K. Skrumsager
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 218 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The relationship between Taq1 A polymorphism of dopamine D 2 receptor (DRD 2 ) gene and extrapyramidal adverse effects of bromperidol and nemonapride, which are both antipsychotic drugs with selective and potent DRD 2 antagonistic property, was investigated in Japanese schizophrenic inpatients. Twen
The presence of D, dopamine receptors in the parathyroid gland has been proposed based on the demonstration of dopaminergic regulation of adenylate cyclase activity and parathyroid hormone release in dispersed bovine parathyroid cells. Using a radioiodinated D, selective antagonist [12511-SCH 23982,